JANA BAILEY: Open Payments
NPI 1932610979 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 61 payments from 19 companies in 2025. Trend: 2023 $354 · 2024 $924 · 2025 $1,254
Food & beverage: $1,175Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $136 |
| Janssen Biotech, Inc. | 6 | $132 |
| Mallinckrodt Hospital Products Inc. | 1 | $93 |
| PFIZER INC. | 4 | $77 |
| QOL Medical, LLC | 3 | $74 |
| GENZYME CORPORATION | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
Products named: DUPIXENT, TREMFYA, TERLIVAZ, ENTYVIO, VELSIPITY, SKYRIZI, Sucraid, RINVOQ.
Industry payments across GA — which companies pay providers there.
